Enter your login e-mail to the account
Search
- New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Probiotics and their role in prevention and treatment of the H. pylori infection
MUDr. Peter Minárik, MUDr. Dušan Ogurčák, MUDr. Tatjana Hanesová
(12/2009, Review articles ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - CURRENT STATE OF EPILEPSY TREATMENT
MUDr. Mária Tormašiová, PhD.
(10/2007, Topic ) - News in the pharmacotherapy of venous disease
MUDr. Karel Roztočil, CSc.
(3-4/2014, Review articles ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - COVID-19, ibuprofén, inhibítory angiotenzín-konvertujúceho enzýmu, sartany
MUDr. Mgr. Jaroslav Hrenák, PhD., MUDr. Kristína Repová, PhD.
(2/2020, Information & comments ) - NOVEL THERAPEUTIC MODALITIES IN PULMONARY HYPERTENSION
doc. MUDr. Iveta Šimková, CSc.
(6/2008, clearly ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - Measurement of arterial stiffness
doc. MUDr. Štefan Farský, CSc., FESC
(4/2009, Review articles ) - Cystic fibrosis in adults
MUDr. Libor Fila, Ph.D.
(4/2015, Review articles ) - Antikoagulační léčba ve stáří
doc. MUDr. Jiří Špác, CSc.
(3/2018, Review articles ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year )
- Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology ) - ANTIEPILEPTIC DRUGS IN THE TREATMENT OF SCHIZOPHRENIA SPECTRUM PSYCHOSES
prof. MUDr. Jan Libiger, CSc., doc. MUDr. Ladislav Hosák, Ph.D.
(4/2008, Review articles ) - Forced medication
MUDr. Alexander Nawka
(2/2013, Review articles ) - Agomelatine in the treatment of anhedonia in patients with major depressive disorder
doc. MUDr. Ľubica Forgáčová, PhD.
(4/2013, Review articles ) - The novel antidepressant agomelatine shows also anxiolytic effects
prof. MUDr. Alexandra Šulcová, CSc.
(4/2011, Drugs & drug classes ) - Mental disorders – epigenetic mechanisms in their etiology and pharmacotherapy
MUDr. Bc. Libor Ustohal, Ph.D., prof. MUDr. Ladislav Hosák, Ph.D., doc. MUDr. Klára Látalová, Ph.D., RNDr. Aleš Kovařík, CSc.
(1/2016, Review articles ) - Chronic insomnia
MUDr. Lucie Závěšická, Ph.D.
(1/2016, Review articles ) - Agomelatine – first results from trial VALID in Slovakia
prof. MUDr. Vladimír Novotný, CSc., doc. MUDr. Ján Pečeňák, CSc.
(1/2011, Original articles & case reports ) - CURRENT TRENDS IN THE TREATMENT OF MAJOR PSYCHIATRIC DISORDERS
prof. MUDr. Eva Češková, CSc.
(2/2008, Review articles ) - Nové trendy v léčbě obsedantně kompulzivní poruchy
MUDr. Pavla Stopková, Ph.D.
(2/2018, Review articles ) - Súčasné možnosti a perspektíva liečby negatívnych príznakov schizofrénie
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Zuzana Vančová, PhD.
(2/2018, Review articles ) - Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles ) - Tardive Dyskinesia - risk factors and practical experience in its treatment.
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, prof. MUDr. Jaroslav Bouček, CSc.
(5/2002, Review articles ) - Nově registrovaná psychofarmaka ovlivňující vigilitu
doc. MUDr. Karel Šonka, CSc.
(1/2001, Psychopharmacology ) - Partial dopamine agonism as a next antipsychotic generation concept?
MUDr. Jozef Dragašek, PhD.
(3/2015, Psychopharmacology ) - Circadian rhythms and depression
MUDr. Michal Maršálek, CSc.
(2/2012, Review articles ) - NEW SYNTHETIC DRUGS
MUDr. Tomáš Páleníček
(5/2005, Review articles ) - Compliance in the Treatment of Schizophrenia
MUDr. Luboš Janů, Ph.D., MUDr. Sylva Racková
(5/2004, Review articles ) - Clozapine and amisulprid combination in treating of pharmaco-resistant schizophrenia
MUDr. Matúš Virčík
(4/2016, Original articles & case reports ) - Optimization of psychopharmacotherapy in schizophrenia
prof. MUDr. Eva Češková, CSc. , MUDr. Michaela Vrzalová
(1/2013, Review articles ) - Adherence and patient’s attitudes to antipsychotic medication
doc. MUDr. Radovan Přikryl, Ph.D., PhDr. Hana Kučerová, Ph.D.
(4/2009, Review articles ) - Multifunctional molecules for treatment of multifactorial diseases
MUDr. Jozef Dragašek, PhD.
(4/2015, Psychopharmacology ) - POSSIBILITIES OF COMBINATION OF PSYCHOTHERAPEUTICS IN CLINICAL PRACTICE
prof. MUDr. Eva Češková, CSc., MUDr. Tomáš Kašpárek
(1/2003, Review articles ) - SECOND GENERATION ANTIPSYCHOTICS IN TREATMENT OF ACUTE PSYCHOTIC AGITATION
MUDr. Pavel Mohr, Ph.D.
(2/2003, Review articles ) - Ziprasidone in the treatment of manic and mixed episodes of mild to moderate severity in patients with bipolar or schizoaffective disorder
MUDr. Dalibor Janoška, MUDr. Jozef Vido, MUDr. Petra Hermanová
(S1/2011, Original articles & case reports ) - Sexual function in the treatment of depressive disorder with agomelatine
MUDr. Jana Novotná, prof. MUDr. Alexandra Žourková, CSc., MUDr. Marta Holanová
(1/2012, Original articles & case reports ) - METABOLIC SYNDROME IN PSYCHIATRY
doc. MUDr. Vladimír Pidrman, Ph.D., doc. MUDr. Jiří Horáček, CSc.
(5/2005, Review articles ) - Adverse effects of antipsychotic treatment
Prof. RNDr. Ludmila Kameníková, DrSc., Mgr. Jan Pomykacz, prof. Dr. Hassan Farghali, DrSc.
(3/2016, Review articles ) - Máme důkazy pro účinnost vysokých dávek olanzapinu?
MUDr. Martin Hýža
(3/2018, Review articles ) - Pharmacotherapy of child and adolescent psychiatry
doc. MUDr. Eva Malá, CSc.
(2/2014, Review articles )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Fycompa® (perampanel): a novel drug for treating epilepsy
prof. MUDr. Ivan Rektor, CSc.
(3/2015, Pharmacotherapy ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - Safety aspects of treating relapsing-remitting multiple sclerosis
MUDr. Radek Ampapa, MUDr. Stanislav Kopecký
(5/2016, Review articles ) - Treating Alzheimer’s disease and related neurodegenerative dementias
doc. MUDr. Roman Jirák, CSc.
(6/2009, From the boundary of neurology ) - Juvenile form of Huntington's disease
doc. MUDr. Jan Roth, CSc.
(3/2012, Main topic ) - Novel approaches in pharmacological treatment of epilepsy
MUDr. Jana Zárubová , Prof. MUDr. Petr Marusič, Ph.D.
(3/2021, Main topic ) - NOVÁ ANTIEPILEPTIKA U DOSPĚLÝCH – NOVÉ INFORMACE
prof. MUDr. Ivan Rektor, CSc.,
(2/2007, Main topic ) - NEŽÁDOUCÍ ÚČINKY NOVÝCH ANTIEPILEPTIK
MUDr. Ivana Tyrlíková
(2/2007, Main topic ) - Painful diabetic neuropathy
prof. MUDr. Zdeněk Ambler, DrSc.
(1/2012, Review articles ) - Subcortical band heterotopia of the cerebral cortex with pharmacoresistant epilepsy
prof. MUDr. Petr Kaňovský, CSc., doc. MUDr. Robert Kuba, Ph.D., doc. MUDr. Stanislav Buřval, Ph.D., MUDr. Milan Labonek, MUDr. Marta Neklanová, MUDr. Jindřiška Burešová, prof. MUDr. Roman Herzig, Ph.D.
(1/2012, Case reports ) - Treatment of delirium
doc. MUDr. Ján Pečeňák, CSc.
(5/2011, Main topic ) - The importance of magnetic resonance imaging in monitoring of disease activity of multiple sclerosis – a clinical neurologist insight
doc. MUDr. Manuela Vaněčková, Ph.D., MUDr. Dana Horáková, Ph.D.
(6/2012, Review articles ) - PEGylated interferon beta-1a: a novel interferon in treating multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(4/2017, Review articles ) - News in farmacological treatment of epilepsy
prof. MUDr. Ivan Rektor, CSc., FCMA, FANA, MUDr. Ondřej Strýček
(2/2015, Main topic ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- Consequences of genitourinary malignancies therapy on cardiovascular system
Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Lucia Petríková, RNDr. Zuzana Poljak Valášková, Ph.D.
(5/2018, Review articles )
- Monoclonal antibodies in the treatment of chronic lymphocytic leukemia
MUDr. Eva Mikušková, MUDr. Ľudmila Demitrovičová, MUDr. Juraj Chudej, PhD.
(6/2014, Oncohematology Review ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Treatment options in multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(1/2007, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - New insights into the pathophysiology of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2013, Editorial ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - Strategy of use antifungals in the treatment of oncologic patients IFD
doc. MUDr. Ľuboš Drgoňa, CSc.
(4/2014, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Prevention and treatment of anticancer therapy-induced nausea and vomiting
MUDr. Jana Obertová, PhD.
(5/2023, Main topic ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - The current status of biological therapy for relapsed/refractory classical hodgkin lymphoma – a case report
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Ľubica Váleková, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Original articles & case reports ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Cardiovascular complications caused by treatment of hematologic malignancies
Prof. MUDr. Beata Mladosievičová, PhD.
(4/2017, Review articles ) - Esenciálna trombocytémia – mení sa niečo v diagnostike a liečbe v roku 2018?
Prof. MUDr. Mikuláš Hrubiško, CSc.
(4/2018, Spectrum )
- Progress in the biological treatment of psoriasis
Prof. MUDr. Mária Šimaljaková, PhD
(1/2018, Drugs & drug classes ) - Endocannabinoid system of the skin – novel findings and perspective therapeutic opportunities
doc. MUDr. Dušan Buchvald, CSc.
(1/2013, Review articles ) - BIOLOGICA TREATMENT OF PSORIATIC ARTHRITIS
MUDr. Liliana Šedová, MUDr. Jiří Štolfa
(2/2007, Interdisciplinary overviews ) - View of clinical immunology on targeted therapy of psoriasis
doc. MUDr. Martin Hrubiško, PhD.
(1/2012, Interdisciplinary consilium ) - Antimycotics in dermatological practice
doc. RNDr. Anna Volleková, CSc.
(4/2012, Drugs & drug classes ) - Postherpetic neuralgia and its therapy
MUDr. Robert Opavský
(2/2009, Interdisciplinary consilium )
- LIEČBA MIGRÉNY ELETRIPTANOM
doc. MUDr. Vladimír Donáth, CSc.
(1/2007, clearly ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly )
- Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - The novel antidepressant agomelatine shows also anxiolytic effects
prof. MUDr. Alexandra Šulcová, CSc.
(3/2012, New drugs ) - COVID-19 and the lung: from interstitial pneumonia to pulmonary fibrosis
MUDr. Štefan Laššán, PhD., MPH, MUDr. Monika Laššánová, PhD.
(4/2023, Current pharmacotherapy ) - Anticoagulation therapy – what a pharmacist should know
doc. MUDr. Jana Hirmerová, Ph.D.
(2/2021, Current pharmacotherapy ) - Local drugs for oral mucosa diseases
PharmDr. Jan Gajdziok, Eliška Tajovská, PharmDr. Martina Bajerová, PharmDr. Zuzana Chalupová, Ph.D.
(1/2011, Current pharmacotherapy ) - Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy ) - Prasugrel – a novel antiplatelet agent
doc. MUDr. Otto Mayer, CSc.
(1/2011, New medicinal substances ) - Huperzine A and other natural substances in treating Alzheimer's disease
PharmDr. Jan Martin, Mgr. Zuzana Kršková, doc. RNDr. Jaroslav Dušek, CSc.
(2/2011, Phytotherapy ) - Overview of H1 antihistamines intended not only for seasonal pollen allergy
prof. PharmDr. Martin Doležal, Ph.D.
(2/2013, Current pharmacotherapy )
- Microcirculation in intestinal mucosa and its conextion to IBD
MUDr. Petronela Bušíková, PhD., doc. MUDr. Ján Porubský, CSc.
(3-4/2012, Review articles ) - New antiplatelet agents for clinical practise
MUDr. Peter Minárik, PhD., MUDr. Jana Mináriková, MUDr. Miroslav Hoppan
(1-2/2012, Drugs & drug classes ) - Rivaroxaban (XARELTO) – an orally administered anticoagulant for thromboprophylaxis in orthopedic surgery
doc. MUDr. Otto Mayer, CSc.
(3/2010, Drugs & drug classes ) - XXI. Slovenský angiologický kongres spojený so 6. kurzom Central European Vascular Forum
(S3/2013, Supplement )